SOURCE: BioMedical Technology Solutions Holdings

August 31, 2010 07:45 ET

BioMedical Technology Solutions Holdings Shows Commitment to Shareholders as Chief Executive Officer Surrenders 500,000 Warrants

ENGLEWOOD, CO--(Marketwire - August 31, 2010) -  BioMedical Technology Solutions Holdings, Inc. ("BMTS" or "the Company") (OTCBB: BMTL) is pleased to announce that President and CEO, Don Cox, has surrendered 500,000 company warrants back to the Company to reduce the number of issued shares when fully diluted. Mr. Cox has surrendered these shares for no consideration.

The fully diluted share capital of the Company is reduced by 1.40% to 36,112,014 shares with the elimination of the 500,000 warrants. The number of issued and outstanding shares currently is 31,832,398 shares. The daily float of tradable shares of BMTL is under 10 million shares, approximately 30% of the overall outstanding shares.

"In a constant effort to increase shareholder value, I felt that it was important to surrender the warrants to show my personal commitment to BMTS and its shareholders," stated Don Cox. "We are continually moving forward with our business plans through regular meetings with government agencies and major corporations. Our Demolizer® II System is receiving a great deal of interest in the industry as we continue our marketing efforts. We are confident that our shareholders will be rewarded for their patience and loyalty in the near future and the surrendering of the warrants is another way for me to show my dedication to them."

About BioMedical Technology Solutions Holdings, Inc.

BioMedical Technology Solutions Holdings, Inc., located in Englewood, Colorado, sells the Demolizer® II through its wholly owned subsidiary BioMedical Technology Solutions, Inc. BMTS' patented Demolizer® Technology converts infectious biomedical waste into non-infectious material. BMTS' products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the US. For more information, visit www.bmtscorp.com or call 866-525-2687.

About the Demolizer® II

The Demolizer® II is the GREEN alternative to biomedical waste disposal. The device is the only patented, portable, and self-contained system able to process both sharps and typical red bag biomedical waste onsite. The processed waste is rendered sterile and discarded as common trash eliminating up to 100% of the cost associated with its disposal. The Demolizer® II meets or exceeds all EPA and CDC guidelines and is approved or meets treatment requirements in 48 states after review by 80 governmental agencies. The device uses no chemicals or liquids, plugs into a normal outlet through a surge protector, and automatically records and prints state required documentation. The Demolizer® II provides a safer, more environmentally GREEN method for biomedical waste disposal.

Safe Harbor for Forward-Looking Statements

The statements contained in this press release may include certain projections and forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve a number of risks and uncertainties. Such statements reflect the Company's current views with respect to future events and financial performance. No assurances can be given however, that these events will occur or that such expectations will be achieved and that actual results could differ materially from those described. Actual results of future operations of BioMedical Technology Solutions Holdings, Inc. may differ materially from those indicated by these forward-looking statements as a result of various important factors.

Contact Information

  • Contact:
    Don Cox
    BMTL President and CEO
    (303) 653-0100